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Rochus K. Voeller, MD, Marci S. Bailey, RN, Andreas Zierer, MD, Shelly C. Lall, MD, Shun-ichiro Sakamoto, MD,
Kristen Aubuchon, Jennifer S. Lawton, MD, Nader Moazami, MD, Charles B. Huddleston, MD, Nabil A. Munfakh, MD,
Marc R. Moon, MD, Richard B. Schuessler, PhD, and Ralph J. Damiano, Jr, MDObjectives: The importance of each ablation line in the Cox maze procedure for treat-
ment of atrial fibrillation remains poorly defined. This study evaluated differences in
surgical outcomes of the procedure performed either with a single connecting lesion
between the right and left pulmonary vein isolations versus 2 connecting lesions (the
box lesion), which isolated the entire posterior left atrium.
Methods: Data were collected prospectively on 137 patients who underwent the Cox
maze procedure from April 2002 through September 2006. Before May 2004, the pul-
monary veins were connected with a single bipolar radiofrequency ablation lesion
(n 5 56), whereas after this time, a box lesion was routinely performed (n 5 81).
The mean follow-up was 11.8 6 9.6 months.
Results: The incidence of early atrial tachyarrhythmia was significantly higher in the
single connecting lesion group compared with that in the box lesion group (71% vs
37%, P , .001). The overall freedom from atrial fibrillation recurrence was signifi-
cantly higher in the box lesion group at 1 (87% vs 69%, P 5 .015) and 3 (96% vs
85%, P 5 .028) months. The use of antiarrhythmic drugs was significantly lower
in the box lesion group at 3 (35% vs 58%, P 5 .018) and 6 (15% vs 44%, P 5
.002) months.
Conclusions: Isolating the entire posterior left atrium by creating a box lesion instead
of a single connecting lesion between the pulmonary veins showed a significantly
lower incidence of early atrial tachyarrhythmias, higher freedom from atrial fibrilla-
tion recurrence at 1 and 3 months, and lower use of antiarrhythmic drugs at 3 and 6
months. A complete box lesion should be included in all patients undergoing the
Cox maze procedure.
A
trial fibrillation (AF) is the most common sustained arrhythmia in the world,
and its prevalence increases with age.1,2 AF is associated with significant
health care costs and is becoming a serious public health issue as our aging
population continues to expand.3-5 In fact, AF is accountable for about a quarter of all
strokes in patients older than 80 years.4
In an attempt to cure this arrhythmia, the Cox maze procedure was developed after
extensive experimental investigation at our institution. Introduced clinically in 1987,
the Cox maze procedure became the gold standard for the surgical treatment of AF.
The operation involved the creation of multiple surgical incisions on the right and
left atria that were hypothesized to interrupt the macroreentrant circuits thought to
be responsible for sustaining AF.6 The final iteration of the procedure, the Cox
maze III procedure, was proved to be highly efficacious, with excellent long-term
results.7-9 However, it was not widely accepted by practicing surgeons because of
its technical complexity, invasiveness, and associated morbidity.
To simplify the procedure, groups around the world have recently used various en-
ergy sources to create linear lines of ablation on the atria to replace most of the inci-
sions of the Coxmaze III procedure.10-13 Ablation technology has made the procedure
From the Division of Cardiothoracic Sur-
gery, Washington University School of
Medicine, Barnes-Jewish Hospital, Saint
Louis, Mo.
Ralph Damiano reports consulting and lec-
ture fees from Atricure, Medtronic, and
Medical CV and grant support from Atricure
and Estech. Charles Huddleston reports
equity ownership in Medtronic. Richard
Schuessler reports lecture fees from Atricure
and grant support from Atricure and Med-
tronic.
Supported in part by National Institutes of
Health grants R01 HL032257-21 and F32
HL082129-02.
Read at the Eighty-seventh Annual Meeting
of The American Association for Thoracic
Surgery, Washington, DC, May 5-9, 2007.
Received for publication May 3, 2007;
revisions received Sept 12, 2007; accepted
for publication Oct 26, 2007.
Address for reprints: Ralph J. Damiano, Jr,
MD,Washington University School ofMed-
icine, Barnes-Jewish Hospital, Suite 3108
Queeny Tower, 1 Barnes-Jewish Hospital
Plaza, Saint Louis, MO 63110 (E-mail:
damianor@wustl.edu).
J Thorac Cardiovasc Surg 2008;135:870-7
0022-5223/$34.00
Copyright  2008 by The American Asso-
ciation for Thoracic Surgery
doi:10.1016/j.jtcvs.2007.10.063870 The Journal of Thoracic and Cardiovascular Surgery c April 2008
Voeller et al Surgery for Acquired Cardiovascular Disease
A
CDAbbreviation and Acronym
AF 5 atrial fibrillation
less invasive and more accessible to cardiac surgeons world-
wide. At our institution, bipolar radiofrequency energy was
chosen to replace the surgical incisions after extensive exper-
imental studies.14-16 The bipolar radiofrequency ablation–
assisted Cox maze procedure, termed the Cox maze IV
procedure, has had excellent results and has significantly
shortened cardiopulmonary bypass and crossclamp
times.17-21 A propensity analysis recently performed on
patients who underwent either the Cox maze III or the Cox
maze IV procedure found no difference in freedom from
AF recurrence at 1 year.22
The lesion set created in the ablation-assisted Cox maze
IV procedure (Fig 1) is patterned after the original cut-and-
sew Cox maze III lesion set. This original lesion set was em-
pirically based, and the importance of each of the incisions/
ablations in the lesion set has not been well defined.
The Cox maze IV procedure has been used exclusively by
our group for the surgical treatment of AF since its clinical
debut in 2002. The lesion set has remained the same over
this time, with the exception of the technique to connect
the right and left pulmonary veins (Figs 1 and 2). Initially,
the right and left pulmonary vein lesions were connected
only inferiorly with a single ablation line (nonbox lesion),
leaving the posterior left atrium in electrical continuity with
the remaining atrium.More recently, the right and left pulmo-
nary vein lesions were connected both superiorly and inferi-
orly by using bipolar radiofrequency ablation, thereby
completely isolating the posterior left atrium (box lesion).
The effect of completely electrically isolating the posterior
left atrium in the Cox maze procedure, which is simply
performed through the addition of a second ablation line
between the superior right and left pulmonary veins, is
unknown. Therefore the purpose of this study was to investi-
gate the difference in outcomes between patients who under-
went the Cox maze IV procedure with either the nonbox or
the box lesion set in the posterior left atrium.
Materials and Methods
From April 2002 through September 2006, 137 patients underwent
the bipolar radiofrequency ablation–assisted Coxmaze IV procedure
at Barnes-Jewish Hospital. From April 2002 through May 2004, all
except 1 patient underwent the Coxmaze IV procedure with the non-
box lesion set (n5 56). From June 2004 through October 2006, the
Cox maze IV procedure with the box lesion was performed in all but
2 patients (n5 81). All operations were performed by the same sur-
geon (R.J.D.). One hundred twenty-one patients underwent the Cox
maze procedure with the bipolar radiofrequency ablation system At-
ricure Isolator (Atricure, Inc, Cincinnati, Ohio). Sixteen patients had
the procedure with the Medtronic Cardioblate BP Surgical AblationThe Journal of ThoFigure 1. Posterior view of the atria illustrating the complete Cox
maze IV lesion set. Patients either had a single ablation line con-
necting the inferior right and left pulmonary veins (nonbox lesion
set) or had an additional ablation line connecting the superior right
and left pulmonary veins (box lesion set), which electrically iso-
lated the posterior left atrium.SVC, Superior vena cava; IVC, inferior
vena cava; Lt, left; Rt, right. Adapted from Lall SC, Melby SJ, Voeller
RK, ZiererA, BaileyMS,Guthrie TJ, et al. Theeffect of ablation tech-
nology on surgical outcomes after the Cox-maze procedure: A pro-
pensity analysis. J Thorac Cardiovasc Surg. 2007;133:389-96.
Figure 2. Endocardial view of the left atrium. Patients either had
a single ablation line connecting the inferior right and left pulmo-
nary veins (nonbox lesion set) or had an additional ablation line
connecting the superior right and left pulmonary veins (box lesion
set), which electrically isolated the posterior left atrium. RF, Radio-
frequency. Adapted from Gaynor SL, Diodato MD, Prasad SM, Ishii
Y, Schuessler RB, Bailey MS, et al. A prospective single-center
clinical trial of a modified Cox maze procedure with bipolar radio-
frequency ablation. J Thorac Cardiovasc Surg. 2004;128:535-42.racic and Cardiovascular Surgery c Volume 135, Number 4 871
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CDSystem (Medtronic, Inc, Minneapolis, Minn). This study was ap-
proved by the Washington University School of Medicine Institu-
tional Review Board. Informed consent and permission for release
of information were obtained from each patient.
Surgical Technique
The Cox maze IV procedure was performed by using cardiopulmo-
nary bypass with bicaval cannulation.23 Patients underwent either
a median sternotomy or a right minithoracotomy.24 Initially, the
heart was perfused at 36C to maintain sinus rhythm and to measure
pacing thresholds from the pulmonary veins. The right and left
pulmonary veins were bluntly dissected. If the patient was in AF,
amiodarone was administered, and the patient was cardioverted.
The pulmonary veins were then isolated by placing the jaw of the
bipolar radiofrequency ablation device on the cuff of the atrial tissue
surrounding the right and left pulmonary veins. Electrical isolation
was documented after ablation by pacing from both the superior
and inferior pulmonary veins at a stimulus strength of 20 mA. In pa-
tients undergoing a right minithoracotomy, pacing was performed
only from the right pulmonary veins.
The patients then underwent a Cox maze IV procedure, as previ-
ously described.17,20,23 Concomitant procedures performed in this
study included coronary artery bypass grafting, mitral valve repair
and replacement, aortic valve replacement, tricuspidvalve replacement,
closure of patent foramen ovale, atrial septal defect repair, left atrial re-
duction, septal myectomy, and resection of an intracardiac tumor.
Postoperative Care and Follow-up
Data were collected prospectively on all patients postoperatively,
and follow-up was 100% complete. Prophylactic antiarrhythmic
drugs were initiated immediately postoperatively, except in patients
with heart block or junctional rhythm. Amiodarone was preferably
used and was continued for 2 to 3 months postoperatively when it
was discontinued if the patient was in sinus rhythm. Patients with
postoperative atrial tachyarrhythmias were cardioverted between 1
and 4 weeks. Unless there were contraindications to anticoagulation,
all patients were started on warfarin for 3 months, at which point it
was discontinued if the patient was in sinus rhythm.
While in the hospital, all patients were continuously monitored
for any arrhythmias. Any early atrial tachyarrhythmias (defined as
AF, atrial flutter, and other supraventricular tachycardias that
occurred within 30 days after the operation) were documented.





(n 5 81) P value
Mean age (y) 62.6 6 11.8 60.2 6 12.6 .274
Male sex (%) 31 (55) 53 (65) .285
AF duration (mo) 83.5 6 86.9 76.6 6 86.9 .649
Paroxysmal AF (%) 35 (63) 51 (63) 1.0
NYHA class 3 or 4 (%) 30 (54) 49 (60) .483
Mean LVEF (%) 48.8 6 13.3 50.2 6 12.1 .543
Failed catheter ablation (%) 6 (11) 10 (12) 1.0
Neurologic indication (%) 3 (5) 0 .066
LA diameter (cm) 5.8 6 1.3 5.3 6 1.3 .055
AF, Atrial fibrillation; NYHA, New York Heart Association; LVEF, left ventric-
ular ejection fraction; LA, left atrium.872 The Journal of Thoracic and Cardiovascular Surgery c ApThe incidence of early postoperative permanent pacemaker place-
ment (within 30 days after the operation) was also recorded. Four-
teen intraoperative and early postoperative outcome variables
were analyzed for both groups of patients (nonbox vs box), which
included cardiopulmonary bypass and crossclamp times, 30-day
operative mortality, myocardial infarction, and stroke.
After discharge, all patients had scheduled office visits at 1, 3,
6, and 12 months, followed by annual visits. At each follow-up
visit, a history, physical examination, and electrocardiogram were
obtained. If a patient could not return to our institution, telephone
interviews were conducted, and electrocardiograms were obtained
from referring physicians to document the heart rhythm. Patients
with symptoms of palpitations were evaluated with electrocardiog-
raphy, prolonged Holter monitoring (.24 hours), or both to assess
their heart rhythm. If patients were implanted with permanent pace-
makers, interrogations were performed to determine the occurrence
of AF. In the later part of our series, patients had 24-hour Holter
monitoring at 3 months.
Data Analysis
Data were collected and entered into a patient database. Continuous
data were expressed as means 6 standard deviations. Categorical
data were expressed as counts and proportions. The clinical profiles
of the 2 groups (nonbox lesion group vs box lesion group) were per-
formed by using the paired t test. The c2 or Fisher exact tests were
used to analyze differences among the categorical data. All statisti-
cal analysis was performed with the SPSS system for statistics
(SPSS, Inc, Chicago, Ill).
Results
Patient Demographics
Patient demographics are categorized in Table 1. The charac-
teristics of the 2 groups were similar because there were no
differences in age, sex, AF type or duration, New York Heart
Association class, left ventricular ejection fraction, or left
atrial diameter between the groups. The mean left atrial diam-
eter was slightly less in the box lesion group. However, it did
not reach statistical significance.
The procedures performed on these patients are detailed in
Table 2. There were no differences in the number of lone
maze procedures. Fourteen (25%) patients in the nonbox
group had ischemic heart disease versus 12 (15%) patients
in the box group.
Perioperative Results
There was no difference in the cardiopulmonary bypass and
crossclamp times between the 2 groups (Table 3). There also
was no difference in operative mortality, incidence of postop-
erative myocardial infarction, stroke, reoperation for bleed-
ing, permanent pacemaker placement, or median intensive
care unit stay. However, there was a trend toward a reduction
in the median hospital length of stay in the box lesion group
(11 vs 9 days, P 5 .074). The only significant difference
between the 2 groups was the incidence of early atrial tachy-
arrhythmias, which was significantly higher in the nonbox
group (71% vs 37%, P , .001).ril 2008
Voeller et al Surgery for Acquired Cardiovascular DiseaseTABLE 2. Operative procedures
Procedure types Total (n 5 137) Nonbox lesions (n 5 56) Box lesions (n 5 81) P value
Lone CM IV (%) 50 (36) 22 (39) 28 (35) .593
CM IV 1 concomitant procedure 87 (64) 34 (61) 53 (65) 2
CM 1 MV procedure 35 14 21 2
CM 1 MV 1 TV procedure 9 4 5 2
CM 1 CABG 11 8 3 2
CM 1 CABG 1 MV procedure 9 4 5 2
CM 1 AV procedure 7 0 7 2
CM 1 AV 1 CABG 5 1 4 2
CM 1 MV 1 AV procedure 3 1 2 2
CM 1 septal myectomy 6 other 4 0 4 2
CM 1 miscellaneous procedure 4 2 2 2
CM, Cox maze procedure; MV, mitral valve; TV, tricuspid valve; CABG, coronary artery bypass graft; AV, aortic valve.A
CDLate Outcomes
No patient was lost to follow-up. The mean follow-up in the
series was 11.8 6 9.6 months. The median follow-up was
9.5 months (range, 0.8–38.2 months). The difference in the
mean follow-up duration between the nonbox and box lesion
groups was statistically significant (19.26 10.3 vs 7.06 5.4
months, P, .001). There was no significant difference in the
use of b-blockers or warfarin at any of the follow-up inter-
vals. The use of b-blockers in the nonbox versus the box
group was 46% versus 60% (P 5 .169) at 6 months and
33% versus 44% (P 5 .399) at 1 year. Similarly, the use of
warfarin in the nonbox group versus the box group at 6
months was 48% versus 43% (P 5 .695) and at 1 year was
48% versus 50% (P 5 1.0).
The overall freedom from AF recurrence (Fig 3) was
significantly higher in the box lesion group at 1 month’s fol-





(n 5 81) P value
Operative mortality (%) 2 (3.6) 2 (2.5) 1.0
Mean CCT (min) 78 6 35 81 6 37 .602
Mean CPB time (min) 188 6 54 180 6 48 .354
Myocardial infarction (%) 0 0 2
Stroke (%) 0 1 (1.2) .513
Reoperation for bleeding (%) 7 (12.5) 3 (3.7) .091
Permanent PM (%) 8 (14.3) 5 (6.3) .143
Early ATA (%) 40 (71.4) 30 (37.0) ,.001
Median ICU LOS (d [range]) 3 (1–61) 2 (1–29) .383
Median hospital LOS
(d [range])
11 (4–61) 9 (4–54) .074
Operative mortality was defined as death within 30 days postoperatively.
Permanent pacemaker placementwas defined as patients receiving a pace-
maker within 90 days postoperatively. Early atrial tachyarrhythmias included
atrial fibrillation and atrial flutter. CCT, Crossclamp time; CPB, cardiopulmo-
nary bypass; PM, pacemaker; ATA, atrial tachyarrhythmias; ICU, intensive
care unit; LOS, length of stay.The Journal of Thorlow-up (87% vs 69%, P5 .015) and at 3 months’ follow-up
(96% vs 85%,P5 .028). There was no statistical difference at
6 months and 1 year. However, in the box lesion group 100%
of patients were free from AF at 1 year. The freedom for AF
recurrence in patients without antiarrhythmic drug use (Fig 4),
on the other hand, was significantly higher in the box lesion
group at 1 month’s follow-up (47% vs 22%, P 5 .004), 3
months’ follow-up (65% vs 42%, P 5 .018), and 6 months’
follow-up (79% vs 54%, P5 .011). There was no statistically
significant difference in the freedom from AF recurrence
without antiarrhythmic drug use between the box lesion and
the nonbox lesion groups at 1 year (83% vs 61%, P5 .138).
Finally, the use of antiarrhythmic drugs (Fig 5) was signif-
icantly less in the box lesion group at 3 months’ follow-up
(35% vs 58%, P 5 .018) and 6 months’ follow-up (15% vs
44%, P 5 .002). Twice as many patients were taking
Figure 3. The overall freedom from atrial fibrillation (AF) recur-
rence was significantly higher for the box lesion group at 1 and
3 months.acic and Cardiovascular Surgery c Volume 135, Number 4 873
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versus the box lesion group (35% vs 17%, P 5 .226). How-
ever, this did not reach statistical significance.
Discussion
The lesion set in the ablation-assisted Coxmaze IV procedure
was designed to recapitulate the cut-and-sew Cox maze III
incisions.17,20,23 The Cox maze procedure was originally
designed as a single operation that would be effective in
terminating AF in all patients.9 Because it was impossible
to define the mechanism of AF in each patient before the op-
eration, the lesion set in the Cox maze III procedure was em-
pirically designed to interrupt all possible macroreentrant
Figure 4. Freedom from atrial fibrillation (AF) recurrence in pa-
tients without antiarrhythmic drug use was significantly higher
in the box lesion group at 1, 3, and 6 months.
Figure 5. Use of antiarrhythmic drugs during follow-up was sig-
nificantly lower in the box lesion group at 3 and 6 months.874 The Journal of Thoracic and Cardiovascular Surgery c Apcircuits.6,25,26 The particular importance of each incision
has remained poorly defined.
The original cut-and-sew Cox maze III procedure isolated
the pulmonary veins by creating one large incision that
encircled all 4 pulmonary veins. This resulted in an akinetic,
electrically isolated posterior left atrium. It was believed that
this might have adverse functional consequences. Moreover,
most of the focal triggers initiating AF originate in the pulmo-
nary veins,27-29 and isolating the entire posterior left atrium
was believed not to be necessary if the pulmonary veins
and surrounding atria were effectively isolated. For these
reasons, in the original Cox maze IV procedure, the superior
and inferior pulmonary veins were isolated together as pairs
on both the right and left sides by using bipolar radiofre-
quency ablation, and a single connecting ablation line was
placed between the right and left inferior pulmonary veins
(Figs 1 and 2). This method electrically isolated all 4 pulmo-
nary veins individually but left the posterior left atrium in
electrical continuity with the rest of the atrium, which was
believed to be a more physiologic approach for preserving
left atrial function.
Since June 2004, we routinely began to perform the Cox
maze IV procedure by isolating the pulmonary veins as
a box, effectively recreating the original circumferential inci-
sion line around all 4 pulmonary veins in the original Cox
maze III procedure. This was done to see whether completely
isolating the posterior left atrium would have an effect on our
results. The box lesion was created by making an additional
ablation line across the dome of the left atrium between the
superior right and left pulmonary veins (Fig 2).
Data from this study demonstrated that the addition of
a single extra ablation line to create the box lesion did not
add any extra crossclamp or cardiopulmonary bypass time.
This is not surprising in that the time for a single bipolar ra-
diofrequency ablation averaged 11.16 4.3 seconds.30 There
was also no effect on postoperative morbidity and mortality.
The most dramatic finding of this study was that isolating
the entire posterior left atrium instead of only the individual
pulmonary veins during the Cox maze IV procedure resulted
in a significant decrease in the incidence of early postopera-
tive atrial tachyarrhythmia. The incidence was decreased by
48%. This likely was the reason for the shorter median length
of hospital stay in the box lesion group because the manage-
ment was simplified without the occurrence of postoperative
atrial tachyarrhythmias.
Late recurrence of AF was lower at 3 months in the box
lesion group. Although there was no difference in recurrence
of AF between the 2 groups at 6 and 12 months, there was
less use of antiarrhythmic drugs at both time points. This is
likely an indicator of less recurrent atrial arrhythmias but
did not correlate with significantly less recurrent AF at these
time points. This probably is a reflection of the posterior left
atrium being an important source for the triggers responsible
for the initiation and the drivers required for the maintenanceril 2008
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catheter ablation literature regarding the importance of the
posterior left atrium because isolating the posterior left
atrium instead of only the pulmonary veins has been associ-
ated with better results.33 Another explanation for the de-
creased incidence of atrial arrhythmias in the box lesion
group is the reduction of the critical mass available for the cir-
culating wavelets responsible for sustaining AF. Our labora-
tory has shown that there is a defined atrial area required to
sustain AF in isolated canine atria.34 If the atrial area was
less than this critical amount, AF was unable to be induced.34
Study Limitations
There were several limitations to this study. The data were
prospectively collected, but patients were not randomized
to each group. Therefore there might have been a selection
bias. However, both groups consisted of unselected consecu-
tive referrals for a Cox maze IV procedure at our institution.
Furthermore, there were no statistically significant differ-
ences in the preoperative demographics between the 2
groups. Although the small difference (0.5 cm) in the mean
left atrial diameter between the 2 groups almost reached
statistical significance (P 5 .055), it is unlikely that this
had an effect on the success of the operation.34
There also was a significant difference in the mean follow-
up between the 2 groups that were compared. This reflects the
fact that the nonbox lesion group was almost exclusively
from before June 2004, and the box lesion has been per-
formed since June 2004 until the present time. Patients
were compared at fixed time points postoperatively rather
than at last follow-up to overcome this bias. Nevertheless,
the possibility of better surgical results from a more recent
study group because of more experience cannot be absolutely
excluded. However, there was no difference in the operative
mortality, in the mean cardiopulmonary bypass time, or in the
mean crossclamp time between the 2 groups. Also, all of the
cases were performed by a single surgeon (R.J.D.), who has
been performing the Cox maze procedure for more than
15 years. It is unlikely that any learning curve phenomenon
was involved in the differences between groups. Finally,
the number of patients in each group was relatively small.
However, follow-up was 100% complete, and the entire
study population was more than 130 patients.
Conclusions
This study demonstrated that completely isolating the poste-
rior left atrium as a box around the pulmonary veins instead
of a single connecting lesion was associated with signifi-
cantly fewer postoperative atrial tachyarrhythmias and
a higher freedom from AF recurrence at 1 and 3 months.
The box lesion group also had the advantage of less antiar-
rhythmic drug use at 3 and 6 months postoperatively. Creat-
ing the box lesion during the Cox maze IV procedure did not
increase operative time or postoperative morbidity and mor-The Journal of Thotality. Therefore the box lesion should be performed to isolate
the posterior left atrium in all patients undergoing the Cox
maze IV procedure.
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Discussion
DrOttavio Alfieri (Milan, Italy). This study, very well presented by
Dr Voeller, is another important contribution coming from a leading
institution with a great tradition and an ongoing prominent scientific
production in the field of surgical treatment of AF. The Coxmaze III
operation has been repeatedly and consistently shown to be the most
effective curative therapy for AF. Although the reproduction of the
standard cut-and-sew procedure using bipolar radiofrequency to
create atrial lesions has been associated with similar results in a pro-876 The Journal of Thoracic and Cardiovascular Surgery c Appensity analysis conducted by the authors, this has not been the case
in other experiences.
At the Mayo Clinic, for instance, the superiority of the cut-and-
sew method over the radiofrequency variant has been clearly docu-
mented in a case-matched study. Therefore efforts to increase the
effectiveness of the bipolar radiofrequency ablation procedure, the
so-called Cox maze IV operation, are fully justified.
There are several reasons to believe that the addition of a second
connecting line is a good move. First, the box lesion is mimicking
more closely the original cut-and-sew Cox maze III operation, in
which a large incision is encircling all 4 pulmonary veins.
Second, the box lesion is achieving a more considerable reduc-
tion of the critical mass necessary to sustain AF.
Third, the posterior free wall of the left atrium is recognized as
a common site of nonpulmonary vein triggers of AF.
Fourth, it is always possible that the single connecting ablation
line is not producing a complete transmural lesion. Although we
are generally confident to produce transmural lesions with bipolar
radiofrequency, we never know for sure, particularly when the atrial
wall is thick, fibrotic, and with a lot of fatty tissue. Furthermore, the
transmurality of that connecting line, which is created on an arrested
heart, is never evaluated electrophysiologically.
Fifth, it is likely that a complete isolation of the posterior left
atrium is producing more functional exclusion of epicardial gangli-
onated plexuses, which has been recognized to have a role in the ini-
tiation and maintenance of AF.
I have a couple of questions for Dr Voeller. First, the negative
aspect of the box lesion is the possible adverse effect on left atrial
function because a large area of akinetic electrically isolated left
atrium is created. Did you investigate the left atrial function with
specific methods in the 2 groups of patients?
My other question is related to the use of antiarrhythmic drugs. A
significant reduction in the use of antiarrhythmic drugs was obtained
in the box lesion groups at 3 and 6 months’ follow-up. This is an
important achievement, which is convincing only if precise and rig-
orous protocols of antiarrhythmic drug administrations are consis-
tently applied over time. Can you tell us which have been the
criteria to give and to stop the antiarrhythmic drugs in your study?
Thank you, and again, congratulations for this excellent article.
Dr Voeller. Thank you, Dr Alfieri, for your kind words. We feel
very honored to have you discuss our studies, and those are excellent
questions. To try to answer your first question, obviously our overall
goal is to do an operation that has a high success rate yet preserves
the normal left atrial function physiologically and mechanically as
much as possible, and there is no question that doing a Cox maze
procedure does have some sort of effect on left atrial function. Un-
fortunately, there are not a lot of studies out there that have system-
atically and in detail looked at this question. We are actually in the
process of looking at this clinically and experimentally using nonin-
vasive magnetic resonance imaging.
Could have my slide up once again please? We do have some
preliminary data from 3 maze patients who underwent preoperative
and 30-day postoperative cardiac magnetic resonance imaging to
look at atrial function and how that is affected from the Cox maze
procedure, and our preliminary results show that reservoir function,
as well as booster pump function, are both negatively affected to
a certain extent at least 30 days after the operation. The conduitril 2008
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CDfunction actually picks up the diminished reservoir and booster
pump function. Therefore the maze procedure does have a negative
effect on atrial function, and further studies are necessary and more
data are required to really know what happens to atrial function and
how long the negative effects persist after the maze procedure.
Having said that, these negative effects on atrial function proba-
bly do not have a large clinical meaning in patients, at least those
with a structurally normal heart with normal left ventricular func-
tion, but that is sort of early to say.
With regard to the posterior left atrium specifically, the reason
why we initially did not do a box lesion early in this series was
because of the fear that producing an akinetic posterior wall by iso-
lating the posterior left atrium, which accounts for about a third of
the total left atrial mass, created a negative effect on the overall
left atrial function, and some authors have actually further stated
that this could actually create an environment for thrombus forma-
tion and put the patient at risk of stroke. However, having said
that, in our experience of doing the Cox maze procedure at
Barnes-Jewish Hospital for 20 years now, our incidence of postop-
erative stroke has been extremely low, less than 0.1% per year, and
at long-term follow-up, well over 90% of our patients are off warfa-
rin. Therefore we are pretty confident that this posterior left atrial
wall akinesis caused by the box lesion has very little clinical signif-
icance, at least in our experience.
To try to answer your second question, we do have strict guide-
lines in terms of antiarrhythmic use after the operation. In patients
who are in normal sinus rhythm after the operation, those patients
are all started on antiarrhythmic drugs, preferably amiodarone, for
2 months. Patients obviously in AF after the operation are also
started on antiarrhythmic drugs. For patients who are in bradycardia
or junctional rhythm, we do not start them on antiarrhythmic drugs
routinely.
At 2 months we obtain an electrocardiogram, and if the patients
are in normal sinus rhythm at that point, we stop the antiarrhythmic
drugs at 2 months. Four weeks after that, so at 3 months’ follow-up,
we get a 24-hour prolonged Holter monitoring at this time, and if
they still remain in sinus rhythm, we stop the warfarin at that point,
at 3 months.
Dr Niv Ad (Falls Church, Va). This is an excellent study and
a very important one. I wonder whether you looked at the subgroup
of patients in whom the nonboxed lesion failed in more detail. In
other words, were they different and more prone to failure with re-
gard to the existence of the number of traditional risk factors for fail-
ure? That is to say, this study might miss the real reason for failure
because of the fact that those variables were not assessed: larger
atria, longer duration of AF, or both. Our practice is to apply the
nonboxed lesion in so-called regular-sized or a little bit oversized
left atria; however, we use a full box lesion and more in those pa-
tients with larger atria. Did you find any correlation?
Dr Voeller. In terms of left atrial size and failure?
Dr Ad. In this specific subgroup of patients in whom failure
occurred, did they have larger atria and longer durations of AF
that might suggest that it is not the lesion that was the strongest pre-
dictor for failure but the subset of patients? I think that this is a very
important group and more interesting than many other groups that
we are reporting about.The Journal of ThoraDr Voeller. We did not look at that specifically. As you men-
tioned, the left atrial size was slightly smaller in the box lesion
group. The mean size was 5.3 cm, as opposed to 5.8 cm in the non-
box lesion group. But we did not investigate your specific question
in this study.
Dr Takashi Nitta (Tokyo, Japan). Your data have proved the
hypothesis of mass theory in AF. The more atrium you isolate, the
higher success rate for AF you get. But we also have to think about
left atrial function, as Dr Alfieri has noted, because the purpose of
AF surgery is not only in the restoration of sinus rhythm but also
in the restoration of significant left atrial transport function to pre-
vent thromboembolic events.
We have shown in an animal study that isolation of the posterior
left atrium results in about a 20% to 30% reduction of the left atrial
transport function compared with bilateral pulmonary vein isolation.
For this reason, I think it is too early to conclude that the box lesion
should be performed in all patients undergoing the Cox maze proce-
dure. I think you can map the posterior left atrium with a mapping
system to define the patients in whom we really need to isolate
the posterior left atrium. Have you ever mapped the patients to
examine whether abnormal activation or reentry arises from the
posterior left atrium?
Dr Voeller. We clinically have not done that.
Dr Damiano. Dr Nitta, what you are asking is whether we have
ever performed intraoperative mapping?
Dr Nitta. Right. Your data have suggested that some patients
might have some kind of triggers or reentry in the posterior left
atrium. Have you ever proved that electrophysiologically?
Dr Damiano. We have performed intraoperative mapping on
between 50 and 60 patients over the years, and we have definitely
seen rotors that have involved areas of the posterior left atrium,
but as opposed to your group, we have not used it to guide therapy
in any way. Most of our maps are generated retrospectively. But
clearly, we have shown, as have many others, as Dr Alfieri pointed
out, that the posterior left atrium is an important site of triggers, non–
pulmonary vein triggers, for paroxysmal AF. We have also seen,
both in our intraoperative mapping and now in body-surface map-
ping, that this area is very involved in the creation and maintenance
of the rotors, which are involved in sustained atrial function.
Dr Masashi Komeda (Kyoto, Japan). Anatomy teaches us that
the posterior left atrial wall, the area surrounded by those 4 pulmo-
nary vein orifices, is embryologically a part of the pulmonary vein,
and thus there is not much muscle. Therefore basically creating
a box lesion does not compromise left atrial function so much. In
our atrial volume reduction maze surgery, we just ignore the func-
tion of that posterior left atrial part, but we still have good results.
Just a comment.
Dr Voeller. Thank you very much for that comment. I actually
had a slide that I wanted to show you from a magnetic resonance
imaging study looking at the 4-chamber view of the heart, and it
clearly shows that the posterior portion of the left atrium does
not move under normal circumstances, or the movement is very
little, because the posterior wall is tethered to the posterior medi-
astinum by the pulmonary veins. But creating a box lesion and cre-
ating that area being akinetic, it probably has very little mechanical
consequence.cic and Cardiovascular Surgery c Volume 135, Number 4 877
